Tokyo, Dec. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060230) titled 'A Multicenter Prospective Observational Study to Evaluate the Incidence of Post-ESD Bleeding in Patients Receiving Antithrombotic Therapy' on Dec. 29.
Study Type:
Observational
Primary Sponsor:
Institute - Nara Medical University
Condition:
Condition - Gastric epithelial neoplasms
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Evaluating the incidence of post-gastric ESD bleeding in patients receiving antithrombotic therapy without second-look endoscopy
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who undergo ESD for gastric epithelial neoplasms
Key exclusion criteria - Patients in whom gastric ESD was discontinued
Patients who underwent closure of the post-ESD ulcer
Patients with unknown antithrombotic medication status
Patients with unknown details regarding post-ESD bleeding
Target Size - 210
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 08 Month 01 Day
Date of IRB - 2025 Year 09 Month 17 Day
Anticipated trial start date - 2025 Year 10 Month 01 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068889
Disclaimer: Curated by HT Syndication.
